tag:blogger.com,1999:blog-4241416962008169508.post6915600493643364048..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: 2013 Thesis: Merck's Stock Is Almost Certain To Rise -- Through At Least The End Of YearUnknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-4241416962008169508.post-18746747148310245952017-11-26T21:34:55.811-05:002017-11-26T21:34:55.811-05:00It ended 2013 at $49.68 -- so a buck better than I...It ended 2013 at $49.68 -- so a buck better than I guessed.<br /><br />Smile. Just about four years late mentioning it, that's all.condorhttps://www.blogger.com/profile/11014613306197942748noreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-79268108349869983262013-05-19T12:26:50.814-04:002013-05-19T12:26:50.814-04:00Okay -- let's set a marker, to get specific:
...Okay -- let's set a marker, to get specific:<br /><br />On Friday, Merck closed at $45.99 on the NYSE.<br /><br />So let's call that $46.<br /><br />My predicition is that, on average, over all the trading days in the month of December 2013 (weighted for daily trading volumes, of course), Merck will have acheived a price in excess of $48.75. <br /><br />That much seems like a lay-up, on the financial levers alone. So, it could be better than that -- but I highly doubt it will be worse than that.<br /><br />That's as granular As I can get, with confidence here at mid-May 2013. [TO be complete, this prediction also appears on the immediately prior post -- where I noted the debt underwriters' conflicts of interest.]<br /><br />Namaste<br /><br />Condorhttp://shearlingsplowed.blogspot.comnoreply@blogger.com